Correlation Between PepGen and Arcturus Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both PepGen and Arcturus Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining PepGen and Arcturus Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between PepGen and Arcturus Therapeutics Holdings, you can compare the effects of market volatilities on PepGen and Arcturus Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in PepGen with a short position of Arcturus Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of PepGen and Arcturus Therapeutics.

Diversification Opportunities for PepGen and Arcturus Therapeutics

0.31
  Correlation Coefficient

Weak diversification

The 3 months correlation between PepGen and Arcturus is 0.31. Overlapping area represents the amount of risk that can be diversified away by holding PepGen and Arcturus Therapeutics Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Arcturus Therapeutics and PepGen is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on PepGen are associated (or correlated) with Arcturus Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Arcturus Therapeutics has no effect on the direction of PepGen i.e., PepGen and Arcturus Therapeutics go up and down completely randomly.

Pair Corralation between PepGen and Arcturus Therapeutics

Given the investment horizon of 90 days PepGen is expected to under-perform the Arcturus Therapeutics. In addition to that, PepGen is 1.62 times more volatile than Arcturus Therapeutics Holdings. It trades about -0.02 of its total potential returns per unit of risk. Arcturus Therapeutics Holdings is currently generating about 0.0 per unit of volatility. If you would invest  2,494  in Arcturus Therapeutics Holdings on November 28, 2024 and sell it today you would lose (838.00) from holding Arcturus Therapeutics Holdings or give up 33.6% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

PepGen  vs.  Arcturus Therapeutics Holdings

 Performance 
       Timeline  
PepGen 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days PepGen has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in March 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.
Arcturus Therapeutics 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Arcturus Therapeutics Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's fundamental indicators remain stable and the newest uproar on Wall Street may also be a sign of mid-term gains for the firm private investors.

PepGen and Arcturus Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with PepGen and Arcturus Therapeutics

The main advantage of trading using opposite PepGen and Arcturus Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if PepGen position performs unexpectedly, Arcturus Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Arcturus Therapeutics will offset losses from the drop in Arcturus Therapeutics' long position.
The idea behind PepGen and Arcturus Therapeutics Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.

Other Complementary Tools

Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites